A heretical view on the role of NO and cGMP in vascular proliferative diseases

Trends in Molecular Medicine

Volumn 11, Issue 2, 2005, Pages 71-75

  Feil, Robert ^a   Feil, Susanne ^a   Hofmann, Franz ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; KT 5823; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANGIOGENESIS; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; DOWN REGULATION; ENZYME ACTIVATION; FUNCTIONAL ASSESSMENT; GENETICS; HYDROLYSIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; SYNTHESIS; TRANSGENIC MOUSE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

MUS MUSCULUS;

EID: 13244275424     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.12.001     Document Type: Article

References (51)

1. F. Hofmann Mouse models of NO/natriuretic peptide/cGMP kinase signaling S. Offermanns L. Hein Handbook of Experimental Pharmacology Vol. 159 2004 Springer-Verlag 95 130
2. J.M. Lablanche Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem Circulation 95 1997 83 89
3. F. Hofmann Rising behind NO: cGMP-dependent protein kinases J. Cell Sci. 113 2000 1671 1676
4. J.A. Beavo, and L.L. Brunton Cyclic nucleotide research - still expanding after half a century Nat. Rev. Mol. Cell Biol. 3 2002 710 718
5. T.M. Lincoln cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression J. Appl. Physiol. 91 2001 1421 1430
6. R. Feil Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice Circ. Res. 93 2003 907 916
7. R. Sarkar, and R.C. Webb Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal J. Vasc. Res. 35 1998 135 142
8. J.Y. Jeremy Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc. Res. 43 1999 580 594
9. G. Walford, and J. Loscalzo Nitric oxide in vascular biology J Thromb Haemost 1 2003 2112 2118
10. H. Koyama Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation J. Cell. Physiol. 186 2001 1 10
11. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
12. V.J. Dzau Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies Nat. Med. 8 2002 1249 1256
13. A. Smolenski Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects Naunyn Schmiedebergs Arch. Pharmacol. 358 1998 134 139
14. M. Burkhardt KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells J. Biol. Chem. 275 2000 33536 33541
15. W. Wolfsgruber A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 13519 13524
16. S. Gambaryan Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase Blood 103 2004 2593 2600
17. S.J. Marshall GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase Blood 103 2004 2601 2609
18. A. Pfeifer Defective smooth muscle regulation in cGMP kinase I-deficient mice EMBO J. 17 1998 3045 3051
19. R. Feil Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms Circ. Res. 90 2002 1080 1086
20. H.K. Hsu YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway Biochem. Pharmacol. 66 2003 263 271
21. J. Chamley-Campbell The smooth muscle cell in culture Physiol. Rev. 59 1979 1 61
22. L.J. Ignarro Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation Proc. Natl. Acad. Sci. U. S. A. 98 2001 4202 4208
23. T.L. Cornwell Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP Am. J. Physiol. 267 1994 C1405 C1413
24. A. Hassid Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells Am. J. Physiol. 267 1994 H1040 H1048
25. N.C. Browner Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells J. Biol. Chem. 279 2004 46631 46636
26. T. Aizawa Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells Circ. Res. 93 2003 406 413
27. N.C. Browner Down-regulation of cyclic GMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells Am. J. Physiol. Cell Physiol. 287 2004 C88 C96
28. M.T. Osinski Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A Mol. Pharmacol. 59 2001 1044 1050
29. J.W. Wegener cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium Circ. Res. 90 2002 18 20
30. D. Metzger, and R. Feil Engineering the mouse genome by site-specific recombination Curr. Opin. Biotechnol. 10 1999 470 476
31. R. Feil Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I J. Cell Biol. 163 2003 295 302
32. T. Kleppisch Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory J. Neurosci. 23 2003 6005 6012
33. S. Massberg Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′-monophosphate kinase I J. Exp. Med. 189 1999 1255 1264
34. Z. Li A stimulatory role for cGMP-dependent protein kinase in platelet activation Cell 112 2003 77 86
35. M. Koeppen cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo Hypertension 44 2004 952 955
36. H. Schmidt cGMP-mediated signaling via cGKIα is required for the guidance and connectivity of sensory axons J. Cell Biol. 159 2002 489 498
37. I. Tegeder Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I Proc. Natl. Acad. Sci. U. S. A. 101 2004 3253 3257
38. H.K. Surks Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Iα Science 286 1999 1583 1587
39. J. Schlossmann Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ Nature 404 2000 197 201
40. P. Sinnaeve Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis Circulation 105 2002 2911 2916
41. D.G. Duda Role of eNOS in neovascularization: NO for endothelial progenitor cells Trends Mol. Med. 10 2004 143 145
42. K. Yamahara Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration Proc. Natl. Acad. Sci. U. S. A. 100 2003 3404 3409
43. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
44. A. Aicher Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells Nat. Med. 9 2003 1370 1376
45. T.L. Cornwell Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells J. Vasc. Res. 31 1994 330 337
46. G. Lin Effect of cell passage and density on protein kinase G expression and activation in vascular smooth muscle cells J. Cell. Biochem. 92 2004 104 112
47. D. Monks Expression of cGMP-dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery Eur. J. Clin. Invest. 28 1998 416 423
48. M.W. Foster S-nitrosylation in health and disease Trends Mol. Med. 9 2003 160 168
49. P. Hedlund Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice Proc. Natl. Acad. Sci. U. S. A. 97 2000 2349 2354
50. V. Randriamboavonjy Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway J. Exp. Med. 199 2004 347 356
51. Y. Nakamura Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group Am. Heart J. 138 1999 577 585